ZentekZTEK
About: Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.
Employees: 25
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
52% more capital invested
Capital invested by funds: $1.05M [Q3] → $1.6M (+$549K) [Q4]
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
13% more funds holding
Funds holding: 15 [Q3] → 17 (+2) [Q4]
0.19% more ownership
Funds ownership: 1.44% [Q3] → 1.64% (+0.19%) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for ZTEK.
Financial journalist opinion
Based on 6 articles about ZTEK published over the past 30 days









